Telogen effluvium — a patient-decision guide
Telogen effluvium is a specific shedding pattern — a wave of synchronised hair release triggered by a stressor that pushed follicles prematurely from active growth into the resting (telogen) phase. The visible shedding typically appears two-to-four months after the trigger, reflecting the duration of the telogen phase. Telogen effluvium is a description of this shedding pattern rather than a casual catch-all diagnosis; identifying the underlying trigger and distinguishing TE from other causes of shedding is dermatology-led at consultation. This guide explains the biological mechanism, the categories of common triggers, the typical recovery framework, and how the consultation actually approaches the conversation.
What this guide does and does not do
This guide explains telogen effluvium at the principles level — the biological mechanism (synchronised follicle entry into telogen with subsequent wave of release), the typical two-to-four-month onset delay relating shedding to triggering stressor, the categories of common triggers, the diagnostic approach, the recovery framework, and the distinction from pattern hair loss. The framework is consultation-led and explicitly cautious about casual self-diagnosis.
The guide explicitly does not diagnose telogen effluvium in any individual case — confirmation of TE versus other shedding causes is dermatologist-led at consultation. The guide does not diagnose underlying medical contributors including thyroid disorders, anaemia, polycystic ovarian syndrome, postpartum thyroiditis, or any other condition that may underlie the TE picture. These are clinical diagnoses through appropriate medical evaluation. For TE, no commitment is made to specific recovery timelines, full restoration, or fixed outcomes. For specific questions, a dermatologist consultation is the right next step.
The biological mechanism
Hair grows in cycles — anagen (growth, lasting two-to-six years for most scalp follicles), catagen (transition), telogen (resting, lasting two-to-four months), and exogen (release). At baseline, around 85–90% of follicles are in anagen and 10–15% in telogen, producing the everyday shedding of about 50–100 hairs daily.
In telogen effluvium, a stressor pushes a larger-than-normal proportion of follicles prematurely from anagen into telogen. The mechanism may involve inflammatory cytokines, hormonal shifts, nutritional disturbances, or other physiological signals. The synchronised follicles complete telogen together — typically two-to-four months later — and release together, producing the shedding wave; the trigger may have settled by then.
The two-to-four-month onset delay
The telogen phase lasts roughly two-to-four months. When a stressor synchronises follicles into telogen, they complete their resting phase before releasing — so shedding lags the trigger by approximately the telogen duration.
Categories of common triggers
Several categories of stressors commonly trigger telogen effluvium.
Physiological stressors — significant illness with high fever, severe infection, COVID-19 (which has been associated with TE in many patients), major surgery, severe injury or accident, severe blood loss. The body's inflammatory and physiological response to acute illness or trauma can synchronise follicles into telogen.
Hormonal shifts — postpartum (the most common identifiable trigger in women of reproductive age, covered in the postpartum hair fall guide), discontinuation of hormonal contraceptives, menopausal transition. Significant hormonal change synchronises the cycle.
Nutritional contributors — severe weight loss (often from restrictive dieting), iron deficiency, vitamin D deficiency, vitamin B12 deficiency, eating disorders, severe malabsorption, prolonged severe protein restriction. Deficiencies of nutrients critical to hair-cycle quality drive synchronised entry into telogen.
Endocrine disorders — thyroid imbalance (both hypo and hyper), uncontrolled diabetes, other hormonal disturbances.
Medications — many can produce TE, including certain anticoagulants, antithyroid agents, some antidepressants, retinoids, certain blood-pressure medications, beta-blockers, lithium, some psychiatric medications, and immunosuppressants. Medication-induced TE typically resolves with discontinuation.
Severe emotional stress — bereavement, traumatic events, sustained severe stress. The mechanism likely involves stress hormones and inflammatory effect.
Chronic illness flares — autoimmune conditions, chronic inflammatory flares, cancer treatment.
The dermatologist screens systematically across these categories at consultation; multiple contributors often coexist.
The diagnostic pathway
A useful evaluation includes detailed history — onset and pattern of shedding, life events and stressors in the two-to-four months before onset, recent illnesses including any COVID-19 infection, recent medications and dose changes, recent dietary or weight changes, postpartum status if relevant, menstrual pattern in women, mood and stress context, current medical conditions, family history of pattern hair loss.
Examination — scalp inspection for diffuse versus patterned thinning (TE is typically diffuse rather than patterned); hair-pull test (gently pulling on a small section to see how many hairs release; in active TE typically three-to-five or more hairs come away per pull, more than baseline); dermoscopy looking for miniaturisation patterns suggesting concurrent androgenetic component or other patterns.
Investigations selectively where indicated — blood-work for iron studies (ferritin), vitamin D, vitamin B12, thyroid panel; selectively hormonal evaluation; scalp biopsy in atypical or treatment-resistant cases. Where features suggest underlying medical conditions, routing to primary care, gynaecology, or endocrinology is part of the framework.
The recovery timeline
Most patients with identifiable single-trigger TE recover over six-to-twelve months once the trigger is addressed and the hair-cycle resets. The recovery sequence typically involves: shedding settles as the synchronised wave completes its release; new anagen growth becomes visible as short hairs along the hairline and parting (often 1–4 cm in length, sometimes lighter in pigmentation than the surrounding mature hair); density gradually restores over months as the new anagen growth matures; full density restoration typically lags the shedding-stop by several months.
Individual variation is meaningful — some patients recover within months of trigger resolution; some take twelve months or more. Recovery is slower where the trigger persists, where additional triggers occur, where pre-existing pattern hair loss is present, or where chronic contributors are unaddressed.
Treatment supporting recovery
For typical single-trigger TE, the framework is identifying and addressing the trigger, supporting hair-cycle recovery, and patient education with calibrated expectations. Specific medical treatments are typically not needed in straightforward cases because the underlying biology recovers naturally.
Where evaluation identifies a treatable contributor, addressing it supports recovery — iron, thyroid, vitamin D, medication review. Topical minoxidil is occasionally used in selected patients with prolonged or severe shedding.
For typical TE, "doing less" with appropriate trigger-addressing and waiting for cycle reset often produces the same outcome as aggressive intervention. The consultation supports calibrated patience alongside evaluation.
COVID-19 and TE
COVID-19 has been associated with TE in many patients, typically presenting two-to-four months after the infection. The mechanism likely involves the inflammatory and physiological stress of COVID-19 illness pushing follicles into synchronised telogen. The clinical pattern matches typical post-illness TE — diffuse shedding, two-to-four-month onset delay, recovery over six-to-twelve months.
Patients sometimes attribute persistent shedding to "Long COVID" when the underlying mechanism is standard post-physiological-stress TE.
Distinguishing acute and chronic TE
Chronic TE — sustained increased shedding over six months or longer without a clearly identifiable single trigger, or with persistent contributors — has a different framework. The diagnostic approach is more thorough, looking for sustained contributors (chronic illness, sustained nutritional deficiency, untreated thyroid pattern, sustained medication effect, chronic severe stress, occult medical conditions). Some chronic TE has no single identifiable cause and is described as primary chronic TE, often affecting middle-aged women, sometimes overlapping with early female pattern hair loss in ways that warrant careful diagnostic distinction. Management focuses on addressing identified contributors, supporting hair-cycle quality with topical and selectively oral pathways under dermatologist guidance, and managing the long-term picture. The framework here is consultation-led; chronic TE often needs longer-term dermatology involvement.
Indian-context considerations
Indian dermatology practice sees TE with specific contextual contributors. Iron deficiency anaemia is more common, particularly in women across reproductive age, and is one of the most common identifiable contributors to TE in this context. Routine evaluation often identifies iron deficiency that the patient was not aware of. Vitamin D deficiency is widespread despite favourable climate. Thyroid disorders show meaningful prevalence and warrant evaluation in TE workup. Postpartum TE is common.
Restrictive dieting for weight loss is a contributor in selected patients — severe calorie or protein restriction can drive TE that resolves with dietary correction. Severe stress and life-event triggers follow universal patterns. The framework adjusts the diagnostic approach to these contextual factors. Routine evaluation in Indian-context TE consultations often includes iron studies (with ferritin specifically rather than only serum iron), vitamin D, vitamin B12, and thyroid panel as standard. The Indian Skin Treatment Safety Guide covers broader Indian-context considerations.
When TE warrants additional evaluation
Several patterns warrant additional clinical assessment beyond standard TE management. Shedding persisting beyond twelve months without recovery suggests chronic TE or an alternative diagnosis. Shedding alongside features suggesting medical conditions — significant fatigue, weight changes, cold intolerance, palpitations, persistent menstrual irregularity, mood changes — suggests concurrent or underlying medical patterns warranting evaluation. Shedding with patches of complete hair loss suggests possible alopecia areata. Shedding with scarring or smooth patches suggests scarring alopecia warranting urgent dermatology assessment because scarring patterns destroy follicles permanently. Shedding alongside scalp inflammation, scaling, or itching suggests concurrent scalp conditions. Shedding with visible patterned thinning in androgenetic distribution suggests concurrent pattern hair loss.
Booking a dermatologist consultation is the appropriate next step. The framework is thorough rather than dismissive — TE is sometimes the diagnosis but other conditions warrant ruling out.
Practical next steps
Photograph the scalp from multiple angles in identical lighting on multiple days — top of head, parting, hairline. Note when the shedding wave was first noticed and any change in pattern over time. List any significant life events, illnesses, surgeries, fevers, or stressors in the two-to-four months before shedding onset — and earlier if relevant for chronic patterns. Note any recent medication changes including new prescriptions, dose changes, and supplements. Note any recent significant weight loss or dietary changes. Note postpartum status if relevant with delivery date. Note menstrual pattern for adult women. Note any other features — fatigue, cold intolerance, mood changes, weight changes. List family history of pattern hair loss. Bring any prior blood-work results.
Safety, expectation, and honest framing
TE management is typically conservative because the underlying biology recovers naturally in most acute single-trigger cases. Where treatment is considered (topical minoxidil for prolonged or severe cases), the relevant considerations apply. Where underlying medical conditions are identified, treatment of those conditions is led by appropriate medical specialists. The clinic does not commit to specific recovery timelines, full density restoration, or fixed outcomes — recovery follows individual biology and depends on whether contributors persist or are addressed. Calibrated expectations against the typical six-to-twelve-month acute TE recovery, with allowance for individual variation and chronic-TE complexity, produce the most useful experience. The framework explicitly does not diagnose underlying medical or hormonal conditions; those pathways run through primary care, gynaecology, endocrinology, or other appropriate specialties.
Related pages and next reading
Frequently asked questions
What is telogen effluvium?
Telogen effluvium is a specific shedding pattern in which a larger-than-normal proportion of scalp hair follicles synchronise into the telogen (resting) phase together and subsequently release, producing a wave of visible shedding above baseline. The mechanism involves a stressor — physiological, emotional, hormonal, nutritional, or pharmacological — that pushes follicles prematurely from anagen (growth) into telogen. The shedding becomes visible two-to-four months after the trigger because telogen lasts roughly that duration before the follicle releases the hair-shaft. Telogen effluvium is a description of this shedding pattern rather than a casual catch-all diagnosis; the dermatologist's role at consultation is identifying the underlying trigger and distinguishing TE from other causes of shedding.
How is TE different from pattern hair loss?
Different mechanisms and different clinical pictures. Telogen effluvium involves a wave of shedding triggered by an identifiable stressor, with diffuse pattern across the scalp; recovery typically follows once the trigger is addressed and the cycle resets, with most patients regaining their baseline density over six-to-twelve months. Pattern hair loss (androgenetic alopecia) involves progressive miniaturisation of follicles in a recognisable distribution (frontal-vertex in men, central-parting widening in women) driven by genetic-and-hormonal factors, without a wave-like onset, and is chronic-progressive rather than self-limiting. The two can coexist — TE can accelerate visible thinning in patients with concurrent pattern hair loss. Distinguishing them at consultation determines management.
What does this guide do and not do?
This guide explains telogen effluvium at the principles level — the biological mechanism, the typical timeline relating shedding onset to triggering stressor, the categories of common triggers, the diagnostic approach, and the realistic recovery expectations. The framework explicitly does not diagnose telogen effluvium in any individual case — confirmation of TE versus other shedding causes is dermatologist-led at consultation. The guide does not diagnose the underlying medical or hormonal contributors (thyroid disorders, anaemia, polycystic ovarian syndrome, postpartum thyroiditis, others); these are clinical diagnoses through appropriate medical evaluation. The clinic does not commit to specific recovery timelines or full restoration. For specific questions, a dermatologist consultation is the right next step.
What are the common triggers of TE?
Several categories of stressors commonly trigger telogen effluvium. Physiological stressors — significant illness (high fever, severe infection, COVID-19 with its well-documented post-infection TE pattern), major surgery, severe injury or accident. Hormonal shifts — postpartum (the most common identifiable trigger in women of reproductive age), discontinuation of hormonal contraceptives, menopausal transition. Nutritional contributors — severe weight loss, restrictive dieting, iron deficiency, vitamin D deficiency, vitamin B12 deficiency, eating disorders, severe malabsorption. Endocrine disorders — thyroid imbalance (both hypo and hyper), uncontrolled diabetes, other hormonal disturbances. Medications — many medications can produce TE pattern, including certain anticoagulants, antithyroid agents, some antidepressants, retinoids, certain blood-pressure medications, beta-blockers, some psychiatric medications, and others. Severe emotional stress — bereavement, traumatic events, sustained severe stress. Chronic illness flares. The dermatologist screens for trigger categories at consultation.
Why does shedding appear two-to-four months after the trigger?
The telogen phase of the hair-cycle lasts roughly two-to-four months. When a stressor pushes follicles prematurely from anagen into telogen, those follicles enter the resting phase together and complete it together. The synchronised wave of follicles releases their hair-shafts at the end of telogen, producing the visible shedding. This timing-delay between trigger and visible shedding is one of the most useful diagnostic features — patients describe the shedding wave appearing several weeks-to-months after the stressful event, by which time the original trigger may have settled. This delay sometimes makes the connection to the trigger non-obvious; the consultation history identifies the timeline.
How does the dermatologist evaluate suspected TE?
A useful evaluation includes detailed history (onset and pattern of shedding, life events and stressors in the two-to-four months before onset, recent illnesses including COVID-19, recent medications and dose changes, recent dietary or weight changes, postpartum status if relevant, menstrual pattern), examination (scalp inspection for diffuse versus patterned thinning, hair-pull test which is typically positive in active TE with three-to-five or more hairs released per pull, dermoscopy to look for miniaturisation patterns suggesting concurrent androgenetic component), and selectively investigations (blood-work for iron studies including ferritin, vitamin D, vitamin B12, thyroid panel; selectively hormonal evaluation, scalp biopsy in atypical or treatment-resistant cases). Where features suggest underlying medical conditions, routing to primary care, gynaecology, or endocrinology is part of the framework.
What is the typical recovery timeline?
Most patients with identifiable single-trigger TE recover over six-to-twelve months once the trigger is addressed and the hair-cycle resets. The recovery sequence is: shedding settles as the synchronised wave completes its release; new anagen growth becomes visible as short hairs along the hairline and parting (often 1–4 cm); density gradually restores over months. Full density restoration typically lags shedding-stop by some months. Individual variation is meaningful. Chronic telogen effluvium — sustained shedding over six months without a single identifiable trigger or with persistent contributors — has a different course; it often takes longer to settle and may require addressing underlying chronic contributors (sustained nutritional deficiency, chronic illness, ongoing severe stress, untreated hormonal pattern).
What treatment supports recovery?
For typical single-trigger TE, the framework is identifying and addressing the trigger, supporting hair-cycle recovery, and patient education with calibrated expectations. Specific medical treatments are typically not needed in straightforward cases because the underlying biology recovers naturally. Where evaluation identifies a treatable contributor — iron deficiency, vitamin D deficiency, thyroid imbalance, ongoing medication contributing to TE — addressing the underlying issue supports recovery. Topical minoxidil is occasionally used in selected patients with prolonged or severe shedding under dermatologist guidance, recognising that effect emerges over months and minoxidil supports rather than transforms recovery. The framework here is honest that for typical TE, "doing less" with appropriate trigger-addressing and waiting for cycle reset often produces the same outcome as aggressive intervention.
What about COVID-19-related TE?
COVID-19 has been associated with TE in many patients, typically presenting two-to-four months after the infection. The mechanism likely involves the inflammatory and physiological stress of COVID-19 illness pushing follicles into synchronised telogen. The clinical pattern matches typical post-illness TE — diffuse shedding, two-to-four-month onset delay, recovery over six-to-twelve months. Patients sometimes attribute "Long COVID hair fall" to ongoing COVID-19 effect when the underlying mechanism is the standard post-physiological-stress TE pattern. Recovery typically occurs in the same timeline as other post-illness TE; reassurance and waiting are often appropriate alongside ruling out concurrent triggers.
When does TE warrant additional evaluation?
Several patterns warrant additional clinical assessment beyond standard TE management. Shedding persisting beyond twelve months without recovery suggests chronic TE or an alternative diagnosis. Shedding alongside features suggesting medical conditions — significant fatigue, weight changes, cold intolerance, palpitations, persistent menstrual irregularity, mood changes — suggests concurrent or underlying medical patterns warranting evaluation. Shedding with patches of complete hair loss suggests possible alopecia areata. Shedding with scarring or smooth patches suggests scarring alopecia warranting urgent dermatology assessment. Shedding alongside scalp inflammation, scaling, or itching suggests concurrent scalp conditions. Booking a dermatologist consultation is the appropriate next step. The framework is thorough rather than dismissive — TE is sometimes the diagnosis but other conditions warrant ruling out.
What about chronic telogen effluvium?
Chronic TE — sustained increased shedding over six months or longer without a clearly identifiable single trigger — has a different framework than acute single-trigger TE. The diagnostic approach is more thorough, looking for sustained contributors (chronic illness, sustained nutritional deficiency, untreated thyroid pattern, sustained medication effect, chronic severe stress, occult medical conditions). Some chronic TE has no single identifiable cause and is described as primary chronic TE, often affecting middle-aged women, sometimes overlapping with early female pattern hair loss in ways that warrant careful diagnostic distinction. Management focuses on addressing identified contributors, supporting hair-cycle quality, and managing the long-term picture. The framework here is consultation-led; chronic TE often needs longer-term dermatology involvement.
What about Indian-context for TE?
Indian dermatology practice sees TE with specific contextual contributors. Iron deficiency anaemia is more common, particularly in women across reproductive age, and is one of the most common identifiable contributors to TE in this context. Vitamin D deficiency is widespread despite favourable climate. Thyroid disorders show meaningful prevalence. Postpartum TE is common. Restrictive dieting for weight loss is a contributor in selected patients. Severe stress and life-event triggers follow universal patterns. The framework adjusts the diagnostic approach to these contextual factors. Routine evaluation in Indian-context TE consultations often includes iron studies, vitamin D, vitamin B12, and thyroid panel as standard. The Indian Skin Treatment Safety Guide covers broader Indian-context considerations.
Practical steps before consultation
Photograph the scalp from multiple angles in identical lighting on multiple days — top of head, parting, hairline. Note when the shedding wave was first noticed. List any significant life events, illnesses, surgeries, fevers, or stressors in the two-to-four months before shedding onset. Note any recent medication changes (new prescriptions, dose changes, supplements). Note any recent significant weight loss or dietary changes. Note postpartum status if relevant with delivery date. Note menstrual pattern for adult women. Note any other features — fatigue, cold intolerance, mood changes, weight changes. List family history of pattern hair loss. Bring any prior blood-work results.
Is this guide medical advice?
No. This guide explicitly does not diagnose telogen effluvium in any individual case, nor does it diagnose underlying medical conditions including thyroid disorders, anaemia, polycystic ovarian syndrome, postpartum thyroiditis, or any other contributor. The framework flags the relevance of evaluation and routes patients to appropriate medical pathways. Specific prescription decisions and individualised plans are dermatologist-led at consultation. For TE, no commitment is made to specific recovery timelines, full restoration, or fixed outcomes. The Medical Disclaimer describes scope and limits.
Book a dermatologist consultation
If a shedding pattern suggesting telogen effluvium is the concern, the right next step is a dermatologist consultation where the underlying trigger pattern can be assessed and any concurrent medical contributors identified for appropriate routing.